PI
AUPH icon

PEAK6 Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

PEAK6 Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-72,239
Closed -$649K – 4017
2023
Q4 		$649K Buy
72,239
+7,207
+11% +$59.4K ﹤0.01% 2428
2023
Q3 		$505K Buy
65,032
+2,255
+4% +$22.1K ﹤0.01% 2386
2023
Q2 		$608K Buy
62,777
+4
+0% +$42 ﹤0.01% 2055
2023
Q1 		$688K Buy
62,773
+5,602
+10% +$49.4K ﹤0.01% 2136
2022
Q4 		$247K Buy
57,171
+33,005
+137% +$192K ﹤0.01% 3123
2022
Q3 		$182K Sell
24,166
-62,771
-72% -$543K ﹤0.01% 3738
2022
Q2 		$851K Buy
86,937
+62,773
+260% +$702K ﹤0.01% 3257
2022
Q1 		$299K Buy
24,164
+15,189
+169% +$235K ﹤0.01% 3571
2021
Q4 		$205K Buy
+8,975
New +$213K ﹤0.01% 3985

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return